Be the new

Commercial Director

in a biotech company focused on the discovery, design and development of innovative peptide-based medicines

Zealand Pharma A/S (Zealand) is a Copenhagen-based biotechnology company focused on the discovery, development, and commercialization of peptide-based medicines. In 2022, we had positive clinical results in two phase 3 programs and are therefore scaling up our commercial efforts to bring new products to the market. To achieve this, we are strategically pursuing global co-development and commercialization partnerships that complement and extend our capabilities to deliver new therapies to patients with unmet medical needs.

Zealand Pharma is seeking a Commercial Director with experience in commercial biotech or pharma in a newly established position. Reporting to the Head of Commercial, Kim Jacobsen, you will leverage your commercial and strategic project management experience in our pursuit to bring novel therapies to the market in the US and beyond.

Who are we?

The Commercial team is characterized by an informal atmosphere with emphasis on an inspiring, lively, and engaging working environment. While we are a high performing team and deeply dedicated to our tasks, we maintain focus on having fun, inclusive, and flexible work culture. As a small company, we support each other’s tasks flexibly and have all ‘hands on deck’ when required.

The commercial department is right now a team of three. We are busy mapping commercialization opportunities for our broad development pipeline and planning of key products in both Europe and US.

The strategy of Zealand Pharma is to find and work with partners for the commercialization, so all the work is in close collaboration with internal as well as external stakeholders. Collaboration and communication both internally and externally are important ways to achieve the ambitious goals of making a significant impact on patient care. We are having broad experience in the team and are looking to further expand this.

Responsibilities include:

Candidate profile

We imagine you have a proven track record of successfully collaborating with many different stakeholders across functions at different organizational levels, including senior level management. Further, we imagine you have most of the below qualifications:

Our work environment provides a high degree of independency thus you need to have an ambitious and proactive attitude towards your work as you drive new and innovative solutions to the challenges we face. You are also an outstanding collaborator, who puts team performance over individual contributions, have a no-blame, and go-getter attitude.

What we offer

Our employees are fundamental to our success, and we continue to be able to attract and retain people with vast experience and talent. We have a unique culture, characterized by excellent teamwork and strong engagement across the organization.

Zealand Pharma DNA builds on four values: (1) We are bold, (2) We empower people, (3) We work as one team, and (4) We can be trusted.

Our work environment is characterized by strong cross functional teamwork, room for individual performance and development, informality and respect, high work-ethics and engagement, and fun. Often, we forget the structures and hierarchies, we roll up the sleeves and get the job done.

At Zealand, we understand the value of a diverse workforce. As an employee, you will be part of an innovative, cross-disciplinary, and cross-cultural working environment.

We offer a combined compensation package which includes a base salary, pension, bonus, and an attractive employee share program. We care about our employees’ well-being and offer health insurance, use of massage, fitness, and a range of social clubs and activities. To find out more about working at Zealand, visit


Please apply no later than February 15, 2023, or as soon as possible. The applications will be reviewed as they come in.

For further information, please contact Kim Jacobsen, Head of Commercial

About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL) ("Zealand") is a biotechnology company focused on the discovery and development of innovative peptide-based medicines. More than 10 drug candidates invented by Zealand have advanced into clinical development, of which two have reached the market. Zealand’s current pipeline of internal product candidates focus on specialty gastrointestinal and metabolic diseases. Additionally, the portfolio includes clinical license collaboration with Boehringer Ingelheim and pre-clinical license collaboration with Alexion Pharmaceuticals. Zealand is based in Copenhagen (Søborg), Denmark. For further information about the Company's business and activities, please visit or follow Zealand on LinkedIn or Twitter @ZealandPharma.